Welcome to Immugen’s website and blog for research. The intent of this blog is to allow the public a venue for expressing their views, scientific insights, and criticisms regarding cannabinoid research and medical use. Immugen is employing a new paradigm in pharmaceutical research: eliciting funding directly from the public and being completely transparent in the use of funds; offering a collaborative environment to exchange and submit research proposals; and more importantly, a mission to alleviate human suffering that is not guided by a pure profit motive.

Please let us know your thoughts as we value the dialogue. As CEO of Immugen, I assure you that I will read all comments and respond accordingly. In the spirit of transparency, you can contact me directly by e-mail bill.massey@immugen.com or by phone 1-760-443-3782. I look forward to your comments and suggestions.

Best regards,

Bill

B.W. Massey, Ph.D.
CEO, Immugen Pharmaceuticals, Inc.